BIO: Dr. Gibbs, CEO and co-founder of Cirsium Biosciences, has devoted his 25+ years of expertise to developing viral vectors and gene therapies to treat genetic diseases. He holds a BS in Zoology and Genetics, as well as a PhD in Anatomy and Physiology from The University of Dundee in Scotland. Following his postdoctoral research on gene therapies for retinal degeneration at the University of California San Diego (UCSD), Dan founded the Salk Institute Viral Vector Core Facility and later worked as an Assistant Professor in Neurosciences at UCSD. He then returned to the Salk Institute as Senior Director of Core Facilities before joining Locanabio, Inc as Senior Director of Vector Development and Engineering. Dan co-founded Cirsium Biosciences in 2019, to develop transformational manufacturing techniques for viral vectors via scalable whole-plant production platforms.